<!DOCTYPE html>
<html>
  <head>
    <title>Prostate cancer</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/mens_health/">mens_health</a></li>
      <li class="active">Prostate cancer</li>
  </ol>

  <div class="page-header">
 
    <h1>Prostate cancer</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Prostate cancer</strong></a>
          <div class="toc">
<ul>
<li><a href="#screening">Screening</a><ul>
<li><a href="#asymptomatic-men">Asymptomatic men</a></li>
<li><a href="#dre">DRE</a></li>
</ul>
</li>
<li><a href="#surveillance">Surveillance:</a></li>
<li><a href="#clinical-assessment">clinical assessment</a></li>
<li><a href="#referenceslinks">References/Links</a></li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <ul>
<li>
<p>greatest incidence of all cancers in NZ</p>
<ul>
<li>16.1% cancer registrations</li>
</ul>
</li>
<li>
<p>91/3% men survived past 5 yrs</p>
<ul>
<li>compared to 61.8% with colon cancer</li>
</ul>
</li>
<li>
<p>majority of men with diagnosis localised prostate cancer undergo definitive treatmetn</p>
<ul>
<li>intent to cure</li>
</ul>
</li>
<li>
<p>generally slow growing:</p>
<ul>
<li>“active survellance”</li>
</ul>
</li>
<li>
<p>low risk = </p>
<ul>
<li>
<p>\&lt;10µg/L</p>
</li>
<li>
<p>gleason score ≤6</p>
</li>
<li>
<p>CLincial stage T1-T2a</p>
<ul>
<li>confimred tumour no more than 1 half of prosate</li>
</ul>
</li>
</ul>
</li>
<li></li>
</ul>
<h3 id="screening">Screening</h3>
<ul>
<li>
<p>PSA = glycoprotein produced by prostate gland</p>
<ul>
<li>
<p>organ specific</p>
</li>
<li>
<p>not cancer specific</p>
</li>
</ul>
</li>
<li>
<p>Free;total PSA</p>
<ul>
<li>
<p>prostate cancer more likely when ratio is low</p>
<ul>
<li>
<p>\&lt;0.25</p>
</li>
<li>
<p>particularly useful when PSA in 4-10 range</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>PSA velocity</p>
<ul>
<li>0.75/yr = commonly used threshold</li>
</ul>
</li>
<li>
<p>prostate gland responsible for liquefying seminal fluid</p>
</li>
<li>
<p>changes to prostate (normal and non cancerous + cancer) = elevation</p>
</li>
<li>
<p>every man has right to decide for himself whether or not to be tested</p>
</li>
<li>
<p>PSA should not be measured within 3d of ejaculation</p>
</li>
<li></li>
</ul>
<p>risk increases with age:</p>
<ul>
<li>
<p>40s</p>
<ul>
<li>1:500 ; \&lt;1:1000 die</li>
</ul>
</li>
<li>
<p>50s</p>
<ul>
<li>1:50; 1:1000</li>
</ul>
</li>
<li>
<p>60s</p>
<ul>
<li>1:14; 1:67</li>
</ul>
</li>
<li>
<p>70s</p>
<ul>
<li>1:9; 1:43</li>
</ul>
</li>
<li>
<p>family history</p>
<ul>
<li>
<p>risk of diagnosis increase </p>
<ul>
<li>
<p>1 relative - 2.5x higher</p>
</li>
<li>
<p>2 rlatives</p>
<ul>
<li>4-5 times higher</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>normal range increases for age</p>
<ul>
<li>
<p>40-49 = 2.5</p>
</li>
<li>
<p>50-59 = 3.5</p>
</li>
<li>
<p>60-69 = 4.5</p>
</li>
<li>
<p>70-79 = 6.5</p>
</li>
</ul>
</li>
<li>
<p>4-10 = mild - moderate inc</p>
</li>
<li>
<p>> 10 = high</p>
<ul>
<li>67% chance that cancer is there</li>
</ul>
</li>
<li>
<p>higher PSA more likely presence of prostate cancer</p>
</li>
<li>
<p>no PSA level can be reassured no cancer</p>
</li>
<li>
<p>non cancerous:</p>
<ul>
<li>
<p>daily variability</p>
</li>
<li>
<p>BPH</p>
</li>
<li>
<p>urinary infection</p>
</li>
<li>
<p>urinary retention</p>
</li>
<li>
<p>prostatitis or sub-clinical prostate inflammation</p>
</li>
<li>
<p>ejaculation</p>
</li>
<li>
<p>DRE</p>
</li>
<li>
<p>prostatic massage</p>
</li>
</ul>
</li>
<li>
<p>elevated PSA -> biopsy</p>
<ul>
<li>
<p>1/4 = cancer</p>
<ul>
<li>bleeding/infection = 1-4%</li>
</ul>
</li>
</ul>
</li>
<li>
<p>for those diagnosed with prostate cancer = 90% go on to have therapy</p>
</li>
<li>
<p>give infomration to those aged 50-70</p>
</li>
<li>
<p>screening must be by both PSA and DRE</p>
<ul>
<li>
<p>PSA only when DRE barrier to testing</p>
</li>
<li>
<p>most prostate cancer in peripheral zone</p>
<ul>
<li>some may be detected by DRE</li>
</ul>
</li>
</ul>
</li>
<li>
<p>if LUTS/systemic features of malignancy</p>
<ul>
<li>PSA, Cr, DRE</li>
</ul>
</li>
<li>
<p>if normal DRE +  PSA \&lt;4 - dont warrnat specialist referral</p>
<ul>
<li>
<p>suspect DRE in patients with PSA up to 2</p>
<ul>
<li>
<p>PPV 5-30%</p>
</li>
<li>
<p>more predictive for more aggressive cancer</p>
</li>
<li>
<p>18% detected by DRE alone</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>refer if:</p>
<ul>
<li>
<p>50-70 PSA ≥ 4</p>
</li>
<li>
<p>71-75: ≥ 10</p>
</li>
<li>
<p>≥ 76: ≥  20</p>
</li>
<li>
<p>palpable abnormal in prostate on DRA</p>
</li>
<li>
<p>signiifant rise in a man whose PSA previously been low</p>
</li>
</ul>
</li>
</ul>
<h4 id="asymptomatic-men">Asymptomatic men</h4>
<ul>
<li>
<p>PSA testing not currently recommended</p>
</li>
<li>
<p>men should make informed decision</p>
</li>
</ul>
<blockquote>
<p>What is prostate?</p>
<ul>
<li>
<p>found only in men</p>
</li>
<li>
<p>lies just beneath bladder</p>
</li>
<li>
<p>normally size of chestnut</p>
</li>
<li>
<p>urethra runs throuhg middle</p>
</li>
<li>
<p>produces fluid which protects and enriches sperm</p>
</li>
<li>
<p>often gets bigger gradually once >50yo</p>
</li>
<li>
<p>by age 70 - 8/10 have enlarged prostate</p>
</li>
<li>
<p>some men develop cancer</p>
</li>
</ul>
<p>What is cancer?</p>
<ul>
<li>
<p>cancer = disease of cells of body</p>
</li>
<li>
<p>abnormal and multiply out of control</p>
</li>
<li>
<p>some can spread to otherparts of body = malignant</p>
</li>
<li>
<p>invade and destroy/damage</p>
</li>
</ul>
<p>Prostate cancer</p>
<ul>
<li>common cause in men</li>
</ul>
<p>Benefits screening</p>
<ul>
<li>
<p>may find prostate cancer at early stage - no symptoms and cancer still wihtin prostate only</p>
</li>
<li>
<p>treatment might cure</p>
</li>
<li>
<p>problems of advanced cancer avoided</p>
</li>
</ul>
<p>Harms</p>
<ul>
<li>
<p>inconclusive as to whether testing better/longer life</p>
</li>
<li>
<p>unecessary medical tests and side effects when no cancer</p>
</li>
<li>
<p>may lead to treatment for a cancer that is slow growing and may not threaten life</p>
</li>
<li>
<p>treatments for prostate cancer may cause permanent side effects and may not result in cure</p>
</li>
</ul>
</blockquote>
<h4 id="dre">DRE</h4>
<ul>
<li>
<p>normal</p>
<ul>
<li>
<p>small</p>
</li>
<li>
<p>2 lobes</p>
</li>
<li>
<p>smooth surfaced</p>
</li>
<li>
<p>symmetircal</p>
</li>
</ul>
</li>
<li>
<p>BPH</p>
<ul>
<li>
<p>enlarges gland</p>
</li>
<li>
<p>preserves symmetry and smoothness</p>
</li>
</ul>
</li>
<li>
<p>cancer</p>
<ul>
<li>
<p>best predictive sign = presence of nodule in prostate</p>
</li>
<li>
<p>hard lump/irregularity</p>
</li>
<li>
<p>lack of central sulcus</p>
</li>
</ul>
</li>
</ul>
<h3 id="surveillance">Surveillance:</h3>
<ul>
<li>
<p>rise in serum PSA usually only indication of a recurrnece in men who have been treated for localised prostate ca</p>
</li>
<li>
<p>PSA = reliable and sinsitive tumour marker</p>
<ul>
<li>
<p>increase in majority of men with recurrent cancer</p>
</li>
<li>
<p>little evidecne that determines frequency</p>
</li>
</ul>
</li>
<li>
<p>PSA testing intervals</p>
<ul>
<li>
<p>men who have undergone radical prostatectomy:</p>
<ul>
<li>
<p>PSA checked;</p>
<ul>
<li>
<p>6wk after treatment</p>
</li>
<li>
<p>6mo first 2 yrs</p>
</li>
<li>
<p>annually</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>active surveillance</p>
<ul>
<li>
<p>q6mo</p>
</li>
<li>
<p>use PSA velocity</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>signoidoscpy q5yrs if radical radiotherpay</p>
<ul>
<li>individual patient basis</li>
</ul>
</li>
<li>
<p>if hormonal treatmnet</p>
<ul>
<li>
<p>androgen blockade</p>
</li>
<li>
<p>DEXA at baseline</p>
</li>
<li>
<p>follow-up DEXA at 12mo or earlier</p>
</li>
</ul>
</li>
<li>
<p>reassess cardiovascular risk</p>
</li>
<li></li>
</ul>
<p>5a-reductase inhibitors (finasteride) reduce PSA levels by approximately 50%</p>
<h3 id="clinical-assessment">clinical assessment</h3>
<ul>
<li>
<p>adverse effects of treatments</p>
<ul>
<li>
<p>urinary</p>
</li>
<li>
<p>sexual dysfunction</p>
</li>
</ul>
</li>
<li>
<p>local recurrence</p>
<ul>
<li>
<p>men initally asymptomatic</p>
</li>
<li>
<p>PSA rise = first</p>
</li>
</ul>
</li>
<li>
<p>symptoms that may suggest metastatic spread - bone pain or weight loss</p>
</li>
<li>
<p>psychosocial aspects</p>
</li>
<li></li>
</ul>
<h3 id="referenceslinks">References/Links</h3>
<p><a href="http://www.prostate.org.nz/documents/diagnosis-management-prostate-cancer-nz-men_(3).pdf">NZ prostate cancer taskforce</a></p>
<p><a href="http://owl.rnzcgp.org.nz/pluginfile.php/18210/mod_resource/content/1/Prostate_Practitioner_Show_Card.pdf">hand out</a></p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
